微生物群组成对结直肠癌患者免疫治疗结果的影响:系统性审查

Suad Mohamed Ajab1, Sumaya Hasan Zoughbor2, Lena Abdulbaset Labania2

  • 1Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, United Arab Emirates.

PloS one
|July 24, 2024
PubMed
概括

肠道微生物群的组成可以预测结直肠癌 (CRC) 对免疫检查点抑制剂 (ICI) 的治疗反应. 像Faecalibacterium和Akkermansia muciniphila这样的特定细菌与更好的结果有关,突出了它们作为预测生物标志物的潜力.